Basic Information
| LncRNA/CircRNA Name | ANRIL |
| Synonyms | NA |
| Region | GRCh38_9:21994778-22121097 |
| Ensemble | ENSG00000240498 |
| Refseq | NR_003529 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | 2 | ||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR etc. |
| Sample | Urine exosome |
| Expression Pattern | up-regulated |
| Function Description | RT-qPCR results showed that ANRIL and PCAT-1 were significantly (p<0.05) higher in the urinary exosomes of BC patients compared with healthy controls. |
| Pubmed ID | 32231490 |
| Year | 2020 |
| Title | Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer |
External Links
| Links for ANRIL | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |